← Leaderboards
Tal Nuriel
Columbia University Health Sciences
$6,961,826
Attributed
$10,194,407
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,194,407 · 9
By mechanism
R01$7,952,266 · 3
R21$891,000 · 2
K01$571,748 · 1
R03$486,000 · 1
F32$169,865 · 1
F31$123,528 · 1
Top collaborators
- Laura Beth Johnson Mcintire4 shared
- Vilas Menon4 shared
- Anna Ruth Cliffe3 shared
- Jia Guo2 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Laura Beth Johnson McIntire$4,565,381
- Gilbert Di Paolo$6,970,861
- Elizabeth M Bradshaw$11,004,520
- Wassim Elyaman$6,169,565
- Vilas Menon$12,301,015
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainApolipoprotein EGenesPreventPathway InteractionsPathogenesisPathologyLate Onset Alzheimer DiseaseGenetic Risk FactorS Disease RiskAffectDisease SusceptibilityAllelesNeuronsEntorhinal CortexBrain RegionExperimental StudyGenotypeNovel Therapeutic InterventionProtein IsoformsBioinformaticsMouse Model
Grant awards (30)
Investigating the role of long-term latent herpes simplex virus infection on APOE4-associated Alzheimer's disease pathogenesis$804,313
R01 · FY2025 · AG · contact PI
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$626,032
R01 · FY2025 · AG
Elucidating the Temporal, Spatial and Cellular Effects of Differential APOE Isoform Expression$541,726
R01 · FY2025 · AG · contact PI
Investigating the role of long-term latent herpes simplex virus infection on APOE4-associated Alzheimer's disease pathogenesis$828,847
R01 · FY2024 · AG · contact PI
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$656,503
R01 · FY2024 · AG
Elucidating the Temporal, Spatial and Cellular Effects of Differential APOE Isoform Expression$540,953
R01 · FY2024 · AG · contact PI
Investigating the role of long-term latent herpes simplex virus infection on APOE4-associated Alzheimer's disease pathogenesis$831,493
R01 · FY2023 · AG · contact PI
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$674,456
R01 · FY2023 · AG
Elucidating the Temporal, Spatial and Cellular Effects of Differential APOE Isoform Expression$569,679
R01 · FY2023 · AG · contact PI
Investigating the cause of APOE4-associated microglial activation and its resulting neurotoxicity of tauopathy-afflicted neurons$97,751
K01 · FY2023 · AG · contact PI
Spatial dysregulation of the lipidome in Alzheimers disease human and mouse brain$709,266
R01 · FY2022 · AG
Elucidating the Temporal, Spatial and Cellular Effects of Differential APOE Isoform Expression$572,268
R01 · FY2022 · AG · contact PI
Investigating the Effects of APOE Genotype on AD Pathology in a Novel AD Mouse Model$243,000
R21 · FY2022 · AG · contact PI
Investigating the cause of APOE4-associated microglial activation and its resulting neurotoxicity of tauopathy-afflicted neurons$97,751
K01 · FY2022 · AG · contact PI
Elucidating the Temporal, Spatial and Cellular Effects of Differential APOE Isoform Expression$596,730
R01 · FY2021 · AG · contact PI
Investigating the Effects of APOE Genotype on AD Pathology in a Novel AD Mouse Model$202,500
R21 · FY2021 · AG · contact PI
Investigating the cause of APOE4-associated microglial activation and its resulting neurotoxicity of tauopathy-afflicted neurons$125,402
K01 · FY2021 · AG · contact PI
Investigating the Effect of APOE4 Expression on AD-relevant Tauopathy$202,500
R21 · FY2020 · AG · contact PI
Utilizing Single-nucleus RNA-sequencing to Investigate the Cell-Type Specific Effects of APOE4 Expression in an AD-vulnerable Brain Region$162,000
R03 · FY2020 · AG · contact PI
Utilizing Single-nucleus RNA-sequencing to Investigate the Cell-Type Specific Effects of APOE4 Expression in an AD-vulnerable Brain Region$162,000
R03 · FY2020 · AG · contact PI
Investigating the cause of APOE4-associated microglial activation and its resulting neurotoxicity of tauopathy-afflicted neurons$125,402
K01 · FY2020 · AG · contact PI
Investigating the Effect of APOE4 Expression on AD-relevant Tauopathy$243,000
R21 · FY2019 · AG · contact PI
Utilizing Single-nucleus RNA-sequencing to Investigate the Cell-Type Specific Effects of APOE4 Expression in an AD-vulnerable Brain Region$162,000
R03 · FY2019 · AG · contact PI
Investigating the cause of APOE4-associated microglial activation and its resulting neurotoxicity of tauopathy-afflicted neurons$125,442
K01 · FY2019 · AG · contact PI
Metabolomic/lipidomic analysis of apoE isoform effects in AD-linked brain regions$58,625
F32 · FY2016 · AG · contact PI
Metabolomic/lipidomic analysis of apoE isoform effects in AD-linked brain regions$56,790
F32 · FY2015 · AG · contact PI
Metabolomic/lipidomic analysis of apoE isoform effects in AD-linked brain regions$54,450
F32 · FY2014 · AG · contact PI
S-Nitrosylation as a Modular of Gamma-Secretase Activity$41,380
F31 · FY2010 · AG · contact PI
S-Nitrosylation as a Modular of Gamma-Secretase Activity$41,176
F31 · FY2009 · AG · contact PI
S-Nitrosylation as a Modular of Gamma-Secretase Activity$40,972
F31 · FY2008 · AG · contact PI